pharma patents
Indian Investment: Has it Lost its Allure?
July 11 by Gerald ClarkeIn the past years businesses had been searching for alternative investment locations and the emerging markets and especially the nations of Brazil, Russia, India and China (BRIC) have attracted part...
Record Patent Filings “Encouraging News” for UK Business
March 07 by Pharma IQ News- Comment from Intellectual Property Specialists Marks & Clerk on 2012 patent filing statistics released by European Patent Office - Statistics from the Annual Report of European Patent Office...
Pharma IQ’s IP Strategies for Crystalline Forms Report
August 04 by Pharma IQ NewsPharma IQ has just published the results of an industry wide IP Crystals Survey, conducted recently among 6,000 patent specialists with over 65 % of those surveyed directly responsible for app...
Europe Remains Most Important for Patent Strategies for 83.3% of Pharma Firms
August 01 by Pharma IQRight across the global pharmaceutical industry, companies are desperately seeking to diversify their product portfolios in anticipation of the countless patent expiries to follow those already seen...
Patent Drafting and Claim Construction
July 15 by Alpesh PathakTo determine whether the patentee has right to exclude for a particular claimed invention, it is essential to know what is claimed and this process is called determining the scope of the inventi...
Should Pharma Focus on New Chemical Entities to Avoid Patent Challenge?
January 20 by Andrea CharlesAs part of the new Pharma Leaders Today series, Philip C. Strassburger, V.P., Intellectual Property Counsel at Purdue Pharma, spoke to Andrea Charles from Pharma IQ, about what trends h...
The Challenges of Patenting in Pharma: Interview with Eric Ruhlmann, Actelion Pharmaceuticals
March 28 by Eric RuhlmannEric Ruhlmann, European Patent Attorney Director, Senior Patent Counsel, Legal Department, Actelion Pharmaceuticals Ltd, joins Pharma IQ, to discuss the latest challenges for patenting pharmaceutic...